From the Department of Biomedical Engineering.
Department of Plastic Surgery, School of Medicine.
Plast Reconstr Surg. 2023 Jan 1;151(1):72e-84e. doi: 10.1097/PRS.0000000000009798. Epub 2022 Oct 7.
Adipose tissue is an easily accessible source of stem and progenitor cells that offers exciting promise as an injectable autologous therapeutic for regenerative applications. Mechanical processing is preferred over enzymatic digestion, and the most common method involves shuffling lipoaspirate between syringes and filtering to produce nanofat. Although nanofat has shown exciting clinical results, the authors hypothesized that new device designs could enhance recovery of stem/progenitor cells through optimization of fluid dynamics principles, integration, and automation.
The authors designed and fabricated the emulsification and micronization device (EMD) and the filtration device (FD) to replace the manual nanofat procedures. Using human lipoaspirate samples, the EMD and the FD were optimized and compared to traditional nanofat using ex vivo measurements of cell number, viability, and percentage of mesenchymal stem cells and endothelial progenitor cells.
The EMD produced results statistically similar to nanofat, and these findings were confirmed for a cohort of diabetic patients. Combining the FD with the EMD was superior to manually filtered nanofat in terms of both recovered cell percentages (>1.5-fold) and numbers (two- to three-fold). Differences were statistically significant for total mesenchymal stem cells and a DPP4 + /CD55 + subpopulation linked to improved wound healing in diabetes.
The new EMD and the FD improved mechanical processing of human lipoaspirate in terms of mesenchymal stem cell enrichment and number compared to traditional nanofat. Future work will seek to investigate the wound healing response both in vitro and in vivo, and to refine the technology for automated operation within clinical settings.
The new devices improved mechanical processing of human lipoaspirate in terms of stem cell enrichment and number compared to traditional methods. Future work will seek to validate wound healing response and refine the technology for automated operation within clinical settings.
脂肪组织是一种易于获取的干细胞和祖细胞来源,作为一种可注射的自体治疗方法,具有令人兴奋的再生应用前景。机械处理优于酶消化,最常见的方法是在注射器之间来回抽吸脂肪抽吸物并过滤以产生纳米脂肪。尽管纳米脂肪已显示出令人兴奋的临床结果,但作者假设通过优化流体动力学原理、集成和自动化,新的设备设计可以提高干细胞/祖细胞的回收率。
作者设计并制造了乳化和微细化装置(EMD)和过滤装置(FD),以取代手动纳米脂肪程序。使用人脂肪抽吸样本,对 EMD 和 FD 进行了优化,并与传统纳米脂肪进行了比较,通过体外测量细胞数量、活力以及间充质干细胞和内皮祖细胞的百分比来进行比较。
EMD 产生的结果在统计学上与纳米脂肪相似,并且这些发现得到了糖尿病患者队列的证实。将 FD 与 EMD 结合使用,在回收细胞百分比(>1.5 倍)和数量(两到三倍)方面均优于手动过滤的纳米脂肪。在总间充质干细胞和与糖尿病伤口愈合改善相关的 DPP4+/CD55+亚群方面,差异具有统计学意义。
与传统的纳米脂肪相比,新的 EMD 和 FD 在间充质干细胞富集和数量方面改善了人脂肪抽吸的机械处理。未来的工作将寻求研究体外和体内的伤口愈合反应,并进一步改进该技术,以实现临床环境中的自动化操作。
与传统方法相比,新设备在干细胞富集和数量方面改善了人脂肪抽吸的机械处理。未来的工作将寻求验证伤口愈合反应,并进一步改进该技术,以实现临床环境中的自动化操作。